Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-mark

Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raisi

Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market

Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-ma

MIAMI, Aug. 19, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth. com a leading independent small cap media p

Aethlon Medical, Inc. (AEMD) Q1 2027 Earnings Call Transcript

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analys

Conference Call Today at 4:30 p.m. ET SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc.

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic

Second cohort findings consistent with previously reported observations; independent statistical ana

Second cohort findings consistent with previously reported observations; independent statistical ana

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to

SAN DIEGO, July 6, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m

Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional

Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul

Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript

Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst

Australian oncology study advances into Cohort 3 as enrollment continues Entered the third and final

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic

https://x.com/PatentGrants/status/2061537506194346238?s=20https://patentcenter.uspto.gov/application

Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to

SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - March 24, 2026) - Investorideas.c

Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investig

SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage bio

SAN DIEGO, March 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq

The Company invites individual and institutional investors, as well as advisors and analysts with an

Aethlon invites individual and institutional investors as well as advisors and analysts, to attend i

Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript

Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.45) per share which beat the analyst

Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conf

$15,000,000 Common Stock From time to time, we may offer and sell shares of our common stock, par va